Home › Dementia › NCT07146581
Technology-Based Intervention Pilot Testing
Primary Care Screening and Intervention for Caregiving Assessment and Support for Patients With Dementia: Technology-Based Intervention Usability and Pilot Testing
Who can join
Ages 21 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Caregiver Inclusion Criteria * 21 years old or older * Provides care for a patient of Weill Cornell Medicine/NewYork-Presbyterian who meets the following criteria: (pilot only) * Patient is at least 60 years old * Patient has diagnosed dementia * Patient requires assistance with at least 1 ADL * Self-identifies as primary informal caregiver for an older adult * Provides 8 or more hours per week of direct care (may include logistics, oversight, observation, as well as hands-on care, but must include at least some in-person assistance) * Can read and speak English at a 6th grade level or above * Not blind or deaf * No active plan to disengage from providing care to the older adult within the next year * Ability to travel to the COA or CABR for study activities and/or attend study session(s) virtually through Zoom on their personal device Caregiver Exclusion Criteria * Non-fluent English speaker * Hired caregiver * Provides care for a patient in hospice care * Too ill or weak to complete the interviews (per the interviewer)
About the study
This research project has three main goals:
(1) To create a new screening tool that helps primary care doctors spot signs of neglect in older adults with dementia. (2) To design a support program that can be delivered both in person and through a mobile app on Android phones. (3) To run a clinical trial with three groups of participants to find out how effective the screening tool is on its own, and how effective it is when combined with the support program-compared to standard care.
This current phase of the project focuses on parts of goals 1 and 2, as described below.
What is being tested
- SIRENS (behavioral)
Sponsor: Weill Medical College of Cornell University · Participants: 40 · Started: Oct 16, 2026
Contact the study team
- Chelsie Burchett, PhD · Phone: 6469627141
Official record on ClinicalTrials.gov — NCT07146581
Locations in the U.S.
| New York | Weill Cornell Medicine, New York |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.